Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024

SELL
$13.56 - $20.78 $20,285 - $31,086
-1,496 Reduced 10.67%
12,523 $180,000
Q4 2023

Feb 14, 2024

BUY
$14.18 - $22.31 $198,789 - $312,763
14,019 New
14,019 $301,000
Q1 2023

May 10, 2023

SELL
$30.17 - $41.11 $3,741 - $5,097
-124 Reduced 1.91%
6,354 $229,000
Q4 2022

Feb 07, 2023

BUY
$36.43 - $49.4 $64,335 - $87,240
1,766 Added 37.48%
6,478 $256,000
Q3 2022

Nov 14, 2022

SELL
$40.66 - $53.03 $62,982 - $82,143
-1,549 Reduced 24.74%
4,712 $220,000
Q2 2022

Aug 12, 2022

BUY
$40.85 - $77.67 $72,141 - $137,165
1,766 Added 39.29%
6,261 $274,000
Q1 2022

May 16, 2022

BUY
$59.95 - $92.06 $16,126 - $24,764
269 Added 6.37%
4,495 $325,000
Q4 2021

Feb 14, 2022

SELL
$81.07 - $121.29 $55,695 - $83,326
-687 Reduced 13.98%
4,226 $343,000
Q3 2021

Nov 15, 2021

SELL
$101.99 - $166.36 $398,678 - $650,301
-3,909 Reduced 44.31%
4,913 $572,000
Q2 2021

Aug 13, 2021

BUY
$141.6 - $179.06 $249,499 - $315,503
1,762 Added 24.96%
8,822 $1.46 Million
Q1 2021

May 14, 2021

BUY
$132.81 - $182.18 $277,705 - $380,938
2,091 Added 42.08%
7,060 $985,000
Q4 2020

Feb 12, 2021

BUY
$138.17 - $184.34 $191,641 - $255,679
1,387 Added 38.72%
4,969 $860,000
Q3 2020

Nov 09, 2020

BUY
$114.09 - $145.51 $73,359 - $93,562
643 Added 21.88%
3,582 $499,000
Q2 2020

Aug 13, 2020

BUY
$89.45 - $129.85 $73,617 - $106,866
823 Added 38.89%
2,939 $351,000
Q1 2020

May 14, 2020

SELL
$70.23 - $144.31 $351 - $721
-5 Reduced 0.24%
2,116 $212,000
Q4 2019

Feb 14, 2020

BUY
$76.41 - $117.54 $162,065 - $249,302
2,121 New
2,121 $249,000

Others Institutions Holding NVRO

About NEVRO CORP


  • Ticker NVRO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 35,387,800
  • Market Cap $133M
  • Description
  • Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It...
More about NVRO
Track This Portfolio

Track Lpl Financial LLC Portfolio

Follow Lpl Financial LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lpl Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lpl Financial LLC with notifications on news.